The authors found PSMA decrease in tumor tissues caused by epigenetic changes of the FOLH1 gene, but treatment with a HDACi revoked this epigenetic downregulation and restored PSMA expression in vivo and in vitro [25]. The gene discussed is FOLH1; the disease is neoplasm.